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Abstract: With the rapid development of “Internet plus”, medical care has entered the era of big data.
However, there is little research on medical big data (MBD) from the perspectives of bibliometrics
and visualization. The substantive research on the basic aspects of MBD itself is also rare. This study
aims to explore the current status of medical big data through visualization analysis on the journal
papers related to MBD. We analyze a total of 988 references which were downloaded from the Science
Citation Index Expanded and the Social Science Citation Index databases from Web of Science and the
time span was defined as “all years”. The GraphPad Prism 5, VOSviewer and CiteSpace softwares
are used for analysis. Many results concerning the annual trends, the top players in terms of journal
and institute levels, the citations and H-index in terms of country level, the keywords distribution,
the highly cited papers, the co-authorship status and the most influential journals and authors are
presented in this paper. This study points out the development status and trends on MBD. It can help
people in the medical profession to get comprehensive understanding on the state of the art of MBD.
It also has reference values for the research and application of the MBD visualization methods.
Keywords: medical big data; bibliometric analysis; visualization; co-citation analysis; co-authorship analysis
1. Introduction
With the rapid development of “Internet plus”, almost all industry and business data shows
explosive growth in recent years [1]. Big data is a common buzzword in business and research
community, referring to great mass of digital data collected from various sources [2]. Big data has the
characteristics of the “5V” [3]:
Variety: the data is from a variety of sources, and the types and formats of data are becoming richer.
It has broken through the category of structured data previously defined, including semi-structured
and unstructured data.
Volume: the volume of data is huge, including the amount of data that is collected, stored
and calculated.
Velocity: it requires fast processing and fast access to high value information for different types of
data, which is fundamentally different from those traditional data mining techniques.
Value: due to the huge amount of data generated with very fast speed and the inevitable formation
of various valid and invalid data, the data density is greatly reduced. However, the rational use of big
data will bring a very high value in return.
Variability: with the increasing use of social media, data load becomes challenging, which usually
results in peak load of data for certain events.
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Big data has received wide attention from the academia, the economic community and even the
government [4]. In May 2011, McKinsey Global Research Institute (MGI) issued a report-Big data:
The next frontier for innovation, competition, and productivity [5]. This study estimated that all companies
stored 7.4EB newly generated data in 2010. It was also the first time for professional organization
to introduce and look into big data. In January 2012, Davos, Switzerland, at the World Economic
Forum, big data was one of the main themes. The report Big Data, Big Impact stated that big date has
become a new category of economic assets [6]. In March 2012, the Obama Administration announced
a “Big Data Research and Development Initiative” [7], which proposed to use big data to break through the
technologies in the fields of scientific research, environmental protection, biological medicine research,
education and national security.
Big data has attracted researchers in all fields, especially in the field of medicine [8]. In 2009,
the Google Corporation analyzed billions of distinctive digital models with billions of search messages
and developed the Google Flu Trends. When the outbreak of influenza A (H1N1) virus occurred in
the United States, the source of influenza was identified in time. Chawla and Davis [9] presented
a big-data-driven approach towards the personalized healthcare. The American Heart Association,
through the investigation of cardiovascular data, proposed a future digital ecosystem for cardiovascular
disease and stroke [10].
Bibliometrics is the cross-disciplinary science of quantitative analysis of all knowledge carriers by
mathematical and statistical methods [11]. It is a commonly used method to identify the development
of a certain field [12,13]. The earliest bibliometrics started in the early twentieth Century. In 1917, Cole
and Eales respectively studied the growth of literature in comparative anatomy through bibliographical
citations [14]. In 1969, the famous British scientist, Allen Richard, first proposed the term “Bibliometrics”
instead of “statistical bibliography”. The emergence of this term marks the formal birth of bibliometrics.
At present, more and more attention has been given to this research. The most obvious advantage
of the bibliometrics is that it allows scholars to study specific research area by analyzing citations,
co-citations, geographical distribution and word frequency, and draw very useful conclusions. Up to
now, the bibliometrics has been widely used in hotspot research [15], co-authorship analysis [16],
co-citation analysis [17], and the development of the whole subject fields [18].
The concept of medical big data (MBD) has been mentioned by more and more people, and has
been widely used in all walks of life. However, the related work mainly concentrates on the engineering
application, specifically on the data collection and storage. However, there is little research on MBD
from the perspectives of bibliometrics and visualization. The visualization not only uses data mining
technology to excavate useful information from data, but also displays the information obtained by data
mining technology to users intuitively. In addition, it is also very important to conduct a systematic
literature review especially at the initial phase of the study about MBD to ensure good quality results.
Therefore, it is necessary for us to make a comprehensive overview on this research direction and find
out some basic patterns of MBD-related research. Motivated by this idea, this paper aims to adopt the
bibliometric analysis and visualization on MBD to explore the characteristics of this area.
The rest of this paper is organized as follows: In Section 2, we introduce the data source and
methods used in this study. Section 3 illustrates the results in detail, including the current status of
MBD study, the analysis of research hotspots, the co-authorship analysis and the co-citation analysis.
Section 4 summarizes the whole paper and significant results are discussed in this section.
2. Data and Methods
The literature data used in this study were downloaded from the Science Citation Index Expanded
(SCIE) and the Social Science Citation Index (SSCI) databases in Web of Science. SCIE and SSCI are
the most frequently-used databases in bibliometric analysis [19–21]. These two databases cover more
scientific and authoritative publications than other databases. What is more, SCIE and SSCI provide
citation information, keywords and references. We took “medical big data” as topical retrieval and the
time span was defined as “all years” (However, according to the returned results, we know that the
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first publication in MBD was appeared in 1991). The literature type was defined as “all types”. In total,
988 documents met the selection criteria. Ten document types were found in these 988 publications.
The most frequent document type is article (807), accounting for 81.7% of total publications. At the
second position is review (98), with a proportion of 10.7%. Other document types including editorial
material (36), proceedings paper (25), meeting abstract (12), book chapter (5), letter (2), book review
(1), correction (1), news item (1). Table 1 lists the numbers and proportions of various document types.
All documents were downloaded on 7 October 2017 in tab separator format.
Table 1. Types of retrieved documents.
Type of Document Frequency Proportion
Article 807 81.7
Review 98 10.7
Editorial material 36 3.6
Proceedings paper 25 2.5
Meeting abstract 12 1.2
Book chapter 5 0.5
Letter 2 0.2
Book review 1 0.1
Correction 1 0.1
News item 1 0.1
Total 988 100
Science mapping is an essential procedure of bibliometrics [22]. It can represent the discipline
situation and development status [23]. There are many softwares for bibliometrics analysis. VOSviewer
(Centre for Science and Technology Studies, Leiden University, Leiden, The Netherlands) and CiteSpace
(Chaomei Chen, China) were used to make visualization mapping in this paper. CiteSpace [24] is
effective in information visualization. It is used to obtain the quantitative and visual information in
specific fields [25]. In this paper, we use CiteSpace to make keywords timeline picture. VOSviewer
is a free software developed by Eck and Waltman [26]. It has a powerful function in co-occurrence
analysis and co-citation analysis. GraphPad Prism 5 (GraphPad Prism Software Inc., San Diego, CA,
USA) was used to make histograms and line charts. There are other kinds of bibliometrics softwares.
Each software has advantages in one or several specific functions. For example, VOSViewer has
a friendly graphical user interface that allows us to view the generated maps easily; Citespace is
capable of visualizing the networks utilizing various layouts [27]. In this paper, we use VOSviewer to
make co-authorship networks and co-citation networks, and then use Citespace to make keywords
timeline view.
3. Results
In this section, we present the results of this paper in details in terms of four parts. The current
status of MBD study is presented in Section 3.1. Section 3.2 introduces the keywords analysis of the
research hotspots on MBD. The co-authorship analysis and the co-citation analysis are displayed in
Sections 3.3 and 3.4, respectively.
3.1. The Current Status of MBD Study
In this part, we discuss the annual trends of MBD-related publications, the distribution of MBD-related
publications in perspectives of institutes and journals, and the citation and H-index analysis.
3.1.1. The Annual Trends of MBD-Related Publications
Figure 1 plots the annual trends of MBD-related publications. Since the first article was published
in 1991, the MBD-related research obtained very slow increase in the following 20 years. Until 2011,
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especially after 2013, more and more scholars started to research in this field. This led to a jump
in the number of publications. There are many reasons for the rapid growth. Firstly, with the
rapid development of internet technology, people were more likely to obtain massive medical data.
Furthermore, in March 2012, the Obama Administration officially launched the Big Data Research and
Development Initiative with an investment of more than US $200 million [7]. The study of big data has
attracted people from all walks of life. More and more countries begun to devote themselves to the
researches and applications of MBD.
Figure 1. The annual trends of MBD-related publications.
3.1.2. The Distribution of Institutes on MBD Study
Harvard University has the greatest number of publications with a total of 16 papers, accounting
for 1.62% of all publications in this field. Bates et al. [28] from the Harvard University presented
six cases to reduce the costs of healthcare through the use of MBD. Their findings have the policy
implications for regulatory oversight, the way to address privacy concerns, and the assist of research on
analytics. At the second position is the University California Los Angeles with 11 publications followed
by the University Michigan, the Northwestern University, and the Stanford University. There are
8 American institutes in the top 10 institutes with 1 Canadian institute and 1 Spanish institute. The top
10 institutes are listed in Figure 2. From Figure 2, we can find that there are less than 100 papers from
the top 10 institutes related to MBD, which implies that MBD is a very new research topic.
Figure 2. The top 10 institutes with MBD-related publications.
3.1.3. The Distribution of Published Journals on MBD Study
All these 988 publications were published in 212 journals. In addition, 155 (73.1%) journals
published no more than 2 papers. It is observed that 9.3% of the publications (92 papers) were
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published in the top 10 journals. The articles are scattered in MBD-related fields. This phenomenon is
mainly because MBD is a new research direction and the study on MBD has not yet formed a systematic
hierarchy. The journal with the greatest number of publications is PLoS ONE, with a total of 16 papers.
Only 2 journals have published more than 10 papers. The top 10 journals that published the most
papers are showed in Figure 3.
Figure 3. The top 10 journals with MBD-related publications.
3.1.4. The Citation and H-Index Analysis
The number of citations is the main factor to reflect the quality of a paper [29]. According to
the analysis of the data from Web of Science, all MBD-related publications were cited 8023 times.
The number of citations from USA was 3644, accounting for 45.4% of the total citations. At the second
position is England with 930 citations.
H-index, also known as H index or H factor (H-factor), stands for “high citations”. In 2005,
an American scientist, Hirsch, proposed to use H-index to evaluate the core scientists for academic
evaluation [30]. A researcher’s H-index means that he/she has at most H papers that were cited at
least H times [31]. H-index was widely deemed as a reliable and authentic parameter to quantify
an individual’s scientific achievements [32]. The USA ranks first with the highest H-index of 29.
Germany’s H-index is 15. China ranks second in the number of articles published (121), but the citation
frequency (510) and the H-index (11) rank sixth and forth, respectively. This implies that the quality
of the publications in China needs to improve, comparing to those top tier countries (Please refer to
Figure 4 for details).
Sustainability 2018, 10, 166 6 of 18
Figure 4. (a) Number of publications; (b) Sum of citations and (c) H-index of MBD-related publications.
3.2. The Keywords Analysis of Research Hotspots on MBD Study
In this part, we study the content by analyzing the distribution of keywords. The keywords
co-occurrence network map, the top 10 keywords in MBD publications, the keywords density
visualization map and the keywords timeline view will be shown.
Keywords co-occurrence can effectively reflect the research hotspots in the discipline fields, providing
auxiliary support for scientific research [33]. In all the 988 MBD-related publications, we obtained
5591 keywords altogether. Among them, 4579 keywords appeared only once, accounting for 81.9%.
The keyword co-occurrence network of MBD (see Figure 5) was constructed by the VOSviewer
software. The size of the nodes and words in Figure 5 represents the weights of the nodes. The bigger
the node and word are, the larger the weight is. The distance between two nodes reflects the strength
of the relation between two nodes. A shorter distance generally reveals a stronger relation. The line
between two keywords represents that they have appeared together. The thicker the line is, the more
co-occurrence they have [34]. The nodes with the same color belong to a cluster. VOSviewer divided the
keywords of MBD-related publications into 7 clusters. The keyword “big data” has a highest frequency
of 203. Other keywords with a high frequency include “care” (70), “risk” (50), and “health-care” (45).
The link strength between two nodes refers to the frequency of co-occurrence. It can be used as
a quantitative index to depict the relationship between two nodes [35]. The total link strength of a node
is the sum of link strengths of this node over all the other nodes. The node, “big data”, has thicker lines
with “care” (19), “risk” (14), “data mining” (12), “machine learning” (13), “electronic health records”
(18), “challenges” (14), “systems” (13), “privacy” (15), and “personalized” (15). These are all the nodes
whose link strengths are greater than 10. The relationships between “big data” and “care” as well as
“risk” imply the close integration of big data and medical treatment. The relationships between “big
data” and “data mining”, “machine mining”, “challenges” and “electronic health record” reflect that
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the MBD study needs the support from some professional techniques. The relationships between “big
data” and “privacy” as well as “personalized” show the development trends of personalized medical
care and the importance of privacy in healthcare. Personalized medicine can be defined as a method
of treatment and prevention of disease, which takes into account the individual variability of genes,
environments and lifestyles in each subject [36]. By taking this approach, it is possible to treat the
right patient at the right time, because preventive measures and treatments can be tailored to each
individual [36]. The top 10 keywords with their frequencies and total link strengths are shown in
Table 2.
Figure 5. Keywords co-occurrence network of MBD-related publications.
Table 2. The top 10 keywords of the MBD-related publications.
Rank Keywords Frequency Total Link Strength
1 Big data 203 597
2 Care 70 220
3 Risk 50 172
4 Health-care 45 152
5 System 43 139
6 Health 43 121
7 Management 34 94
8 The UnitedStates 33 123
9 Epidemiology 32 118
10 Quality 31 95
VOSviewer can make density visualization (see Figure 6). Each node in the keywords density
visualization plat has a color that relies on the density of items at that node. In other words, the color
of a node depends on the number of items in the neighborhood of the node. The keywords in red color
area appear more frequently; on the contrary, the keywords in green color area appear less frequently.
Density views are especially useful for understanding the overall structure of a map and drawing
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attention to the most important areas in the map [9]. From Figure 6, we can see the research focuses of
MBD study intuitively. “big data”, ”care”, “risk” turn out to be important. These keywords are the
core keywords in the MBD study.
Figure 6. Keywords density visualization map of MBD-related publications.
We can make the timeline view by the Citespace software (see Figure 7). It can be seen
from Figure 7 that, before 2000, the research on MBD is little and the keywords of that period
are concentrated on “women”, “mortality” and “pregnancy”. The research on MBD at this stage
is somehow foundational. Entering twenty-first century, the research on MBD began to increase,
and the types of keywords are also very extensive. But the keywords in terms of disease, such
as “diagnose”, “clinical trial”, “cohort”, “breast cancer” and “risk”, account for large proportions.
After 2010, the research issues of MBD had an evolution. There are two main directions: one is the
support technique for big data, like “data mining”, “database” and “machine learning”; the other
is concerning medical care for specific individuals, like “personalized medicine”, “privacy” and
“personality”. This indicates that the MBD study was developing from a disease-centered model
towards a patient-centered model [37]. It is noted that the keyword “big data” showed a trend of
concentration in 2012. This can be partly attributed to the Obama administration’s big data research
and development program. Table 3 lists the keywords of MBD-related publications appeared during
different periods.
Table 3. The keywords of MBD-related publications appeared during different periods.
Periods Keywords
Before 2000 mortality, care, internet, women, intensive care system
2001–2010
Diagnosis, impact, the United States, clinical trial, quality of life, risk, model,
predication, cost, stress, death, anxiety, simulation, complication, birth,
association, cohort, breast cancer
After 2010 Personalized medicine, machine learning, framework, database, datasharing,statement, privacy, personality, China, data mining
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Figure 7. The keywords timeline view of MBD-related publications.
3.3. The Co-Authorship Analysis on MBD
It is difficult for a person to complete a research on a certain subject individually. Many research
projects need collaborative strength to complete. Co-authorship research is an important content of
bibliometrics and the level of research collaboration is an index to assess the current status of research
in a specific field [38]. In this part, we mainly present the country co-authorship analysis, the institute
co-authorship analysis and the highly cited MBD-related publications. We make the co-authorship
network with the help of the VOSviewer software.
3.3.1. The Country Co-Authorship Analysis
Country co-authorship analysis is an important form of co-authorship analysis. It can reflect the
degree of communication between countries as well as the influential countries in this field. The country
co-authorship network of MBD-related publications is showed in Figure 8. There are many colors
in the map, which shows the diversification of research directions. The big nodes represent the
influential countries. The links between nodes represent the cooperative relationships among institutes.
The distance between the nodes and the thickness of the links represent the level of cooperation among
countries. As we can see in Figure 8, the research center in the field of MBD is in the United States and
Asia’s research center is in China. The link strength between the USA and China is 25, between the
USA and England being 17, between the USA and Germany being 13. While the link strength between
England and Germany is 4. It indicates that geographical advantage is not the primary factor that
influences the cooperative relationship.
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Figure 8. The country co-authorship network of MBD-related publications.
3.3.2. The Institute Co-Authorship Analysis
The institute co-authorship network is shown in Figure 9. The Harvard University from the
USA, the University of California Los Angeles from the USA, and the Northwestern University from
the USA are the top three influential institutes of the MBD-related publications. In China, the top
universities include the Peking University, the Huazhong University of Sciences and Technology and
the Zhejiang University.
Figure 9. The institute co-authorship network of MBD-related publications.
3.3.3. The Highly Cited MBD-Related Publications
To identify the most influential papers in the field of MBD, we select the top 10 papers with the
most citations. Table 4 shows these highly cited papers in terms of title, journal, Authors, publication
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year, citation numbers, institute numbers (IN) and country numbers (CN). There are more than
three authors in some papers, and we selected the first three to be shown in Table 3. There are
two highly cited papers published in 1991–2000, 4 papers published in 2001–2010, and 4 papers
published in 2011–2017. All of these 10 papers were co-authored. The average number of authors is 4.9.
In addition, 4 publications were completed through cooperation between institutes. 2 publications were
accomplished by international cooperation. It indicates that it is necessary for authors to cooperate,
and the international co-authorship remains to be strengthened.
Table 4. The top 10 papers with the most citations.
Title Journal Authors Year Citation IN CN
Cachexia as a major underestimated and




von Haehling & Anker 2010 216 1 1
The effect of education and experience on
self-employment success
Journal of Business
Venturing Robinson & Sexton 1994 190 2 2
Assessment of letrozole and tamoxifen alone
and in sequence for postmenopausal women
with steroid hormone receptor-positive breast
cancer: the BIG 1-98 randomised clinical trial
at 8.1 years median follow-up
Lancet Oncology Regan et al. 2011 157 14 9
Balancing accuracy and parsimony in genetic
programming
Evolutionary
Computation Zhang & Muhlenbein 1995 113 1 1
Galactomannan detection for invasive






2008 112 1 1
Meta-analysis in clinical trials revisited ContemporaryClinical Trials DerSimonian & Laird 2015 105 1 1
Evaluation of noise-induced hearing loss in
young people using a web-based survey
technique
Pediatrics Chung, Des Roches &Meunier 2005 98 2 1
Big data in health care: Using analytics to
identify and manage high-risk and high-cost
patients
Health Affairs Bates, Saria &Ohno-Machado 2014 96 5 1
Multimorbidity and quality of life: A closer
look
Health and Quality of
Life Outcomes Fortin, Dubois & Hudon 2007 92 1 1





Sleator 2013 90 1 1
The paper written by von Haehling and Anker [39] ranks first with 216 citations. In this paper,
the authors presented that cachexia is a severe but underestimated aftermath of malignant cancer and
many other chronic diseases with a series of facts and numbers. The work of Robinson and Sexton [40]
occupied the second position. The paper ranked third is “Assessment of letrozole and tamoxifen alone
and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1–98
randomised clinical trial at 8.1 years median follow-up”. In this study [41], an update of curative effect
outcomes was presented. These findings are of guiding significance for the control of breast cancer
recurrence. Zhang and Muhlenbein’s [42] paper ranked fourth, which aims to balance the precision
and cost in genetic programming. The other articles also varied in content, including the application
of big data in medical and the web-based survey on the evaluation of noise-induced hearing loss in
young people.
3.4. The Co-Citation Analysis on MBD-Related Publications
When two items (such as documents, journals and authors) are cited in a citing item’s reference
list, they have a co-citation relationship [14]. Small [43] presented a co-citation analysis to examine the
relationship and structure of academic fields. After that, the co-citation analysis has been extensively
used to reveal the relationship and structure of authors, articles and journals in academic fields. In this
part, the reference co-citation analysis and the journal co-citation analysis are displayed.
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3.4.1. The Reference Co-Citation Analysis
When two papers appeared simultaneously in the third paper’s citations, it is considered that the
two papers established a co-citation relationship [44]. Reference co-citation analysis is an important
mean to detect the structure and evolution path of a specific domain. Co-citation analysis is a kind
of citation network analysis method. It is different from another citation analysis method, namely,
the citation quantity analysis method. The citation quantity analysis method is to evaluate the quality
of the subjects (journal, author, country, document, type of document, etc.) by the number of citations.
Co-citation analysis selects some representative literatures as the analysis object, and then uses the
network analysis method to divide these literatures into several clusters. In this way, we can obtain the
structure and characteristics of a specific domain. In the reference co-citation network, the importance
of nodes does not reveal the high number of citations, but illustrates the research themes that are closely
related to MBD-related research. In this sense, the two methods are based on different target subjects
and the co-citation analysis is limited to the 988 publications. For example, Murdoch TB’s paper was
cited 29 times altogether in those 988 documents, but it was cited 533 times in Google Scholar. Figure 10
shows the reference co-citation network in the field of MBD study. Betweenness Centrality measures
the importance of nodes in a network. The specific calculation method is computed by counting the
percentage that the shortest path between pairwise nodes in the network passes through the node [24].
From Figure 10, we can find that the biggest node is Murdoch (2013). His paper entitled “The Inevitable
Application of Big Data to Health Care” published in JAMA-Journal of the American Medical Association
proposed that the use of patient and physician data collection may be an important way to improve
the quality and efficiency of health care services [45].
Figure 10. The reference co-authorship network of MBD-related publications.
Table 5 lists the top 10 most co-cited documents related to MBD study.
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Table 5. The top 10 most co-cited documents of MBD-related study.
Frequency Betweenness Centrality Author Year
29 0.16 Murdoch TB 2013
17 0.04 Jensen PB 2012
15 0 Lazer D 2014
15 0 Raghupathi W 2014
14 0.04 Marx V 2013
13 0 Ginsberg J 2009
11 0 Mayer-schonberger V 2013
11 0 Manyika J 2011
10 0.08 Bates DW 2014
9 0.02 Dean J 2008
3.4.2. The Journal Co-Citation Analysis
The journal co-citation analysis is not only an efficacious way to study the structure and
characteristics of a subject, but also reveals the overall structure of the subject and the characteristics of
a journal [46]. We use the VOSviewer software to plot the journal co-citation network. Figure 11 shows
the journal co-citation network with 144 nodes. The size of node represents the activity of the journal
and the number of published papers. The distance between two nodes is also very important. Generally,
the smaller the distance between two nodes is, the higher the citation frequency is. As the visualization
illustrated in Figure 11, each cluster has a color that indicates the group to which the cluster is assigned.
We can see that all these journals are divided into five clusters. The red cluster contains JAMA-Journal of
the American Medical Association, New England Journal of Medicine and Lancet, etc. This cluster represents
medical journals. The blue cluster contains Nature, Science and PLoS ONE. This cluster represents
science and technology journals. The green cluster represents information journals.
Figure 11. The journal co-citation network of MBD-related publications.
Table 6 illustrates the distribution of core journals on MBD study. As Table 6 shows, JAMA-Journal
of the American Medical Association has the biggest centrality value (0.25) and it is followed by Lancet
(0.24) and New England Journal of Medicine (0.18).
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Table 6. Distribution of core journals on MBD.
Frequency Centrality Sources Subject
253 0.25 JAMA-J AMMED ASSOC
Computer science, healthcare
sciences& Services, Information science
&Library Science, Medical Informatics
240 0.18 NEW ENGL JMED General & Internal Medicine
177 0.24 LANCET General & Internal Medicine
163 0.10 NATURE Science & Technology
162 0.10 PLOS ONE Science &Technology
134 0.13 SCIENCE Science & Technology
132 0.14 J AM MED
INFORM ASSN
Computer Science
Health Care Sciences & Services
Information Science & Library Science
Medical Informatics
114 0.09 BRIT MED J General & Internal Medicine
86 0.09 HEALTHAFFAIRS Health Care Sciences & Services
84 0.06 ANN INTERNMED General & Internal Medicine
4. Discussions and Conclusions
This study made a bibliometric analysis and visualization on MBD-related publications. We explored
some interesting results concerning the MBD-related publications, which can be summarized as follows:
First, the MBD-related publications fluctuated at low level during the initial periods of 1990s and
the first decade of the 21st century. However, after 2010, the number of publications grown rapidly.
In terms of institutes, the Harvard University has the highest number of publications. The USA has
8 institutes ranked the top 10 regarding to the number of MBD-related publications. The journal,
PLoS ONE, ranks first among the MBD-related journals. The USA has the most publications, the highest
number of citation frequency and H-index. It implies that the USA is the bellwether in this field. China
has a large number of publications, while Chinese scholars should pay attention to the quality of
their papers.
Second, through the analysis of keywords, we have found that medical care is moving from
a disease-centered model towards a patient-centered model. Until now, personalized medicine is
heating up. At the same time, the technical support of MBD study is the key direction that people need
to overcome.
Third, in MBD domain, the phenomenon of cooperation among multiple authors is widespread.
All the top 10 publications with the highest number of citations were completed with more than one
author. However, the international cooperation is not universal.
Fourth, the most frequently cited work in MBD area is Murdoch (2013). JAMA-Journal of the
American Medical Association is most influential in MBD domain.
We can draw a conclusion that the patient-centered model is an inevitable trend in future medical
development. (1) Firstly, precision medicine construction has spread throughout the world, and many
countries have begun to chase the related concepts and industries. In 2008, Clayton Christensen,
professor of Harvard Business School, first proposed the concept of precision. In 2011, National
Research Council formally introduced the definition of precision medicine in the research reporter
Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of
Disease [47]. At the end of January 2015, in the USA, President Obama announced a new project in
the field of life science, namely, Precision Medicine Initiative. This project aims to cure diseases such
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as cancer and diabetes, with the aim of getting everyone healthy with personalized information [48].
Jameson and Longo [49] from the University of Pennsylvania summarized the strengths, challenges
and clinical practice of accelerated precision medicine systematically. Wishart [50] aimed to unmask
the essential reason of complex disease and metabolomics’s potential impact on precision medicine
via exploring the application of metabonomics. Aronson and Rehm [51]’s paper published in Nature
built a medical system with seamless cycling between clinical study and nursing to expedite the
application of precision medicine. There are great improvements in the field of molecular biology, such
as tumor molecular pathology and gene detection. However, the mining, evaluation, integration and
application of these data need to be strengthened. Precision medical information technology systems
include biological samples, bioinformatics, electronic medical records, and big data analysis techniques.
Big data analysis is the key to precision medical treatment [52]. Making good use of MBD can improve
the accuracy and scientific of medical diagnostic, and form the personalized medical care. Through
analyzing the influencing factors of residents’ health, patients’ health information can be integrated to
provide better data evidence for the diagnosis and treatment of the disease. The data mining framework
of precision medical treatment is shown in Figure 12. (2) Secondly, with the continuous progress of
modern society, people’s awareness of safeguarding rights is gradually improved. The protection of
patient privacy has become particularly important. Protecting patient privacy is also an all-around
project [53]. It needs to have privacy laws and legal support agreement. Protecting the privacy
of patients requires the cooperation among all stakeholders, including patients, patients’ health
information holding institutes and government agencies for supervision and enforcement.
Figure 12. Data mining framework for precision medical treatment.
Furthermore, to utilize and develop MBD, the technical challenges cannot be ignored. (1) Firstly,
the expanding medical information data is filled with a large number of unstructured data, and
the data sources are becoming more and more diverse. The storage and transferring technologies
of the MBD are quite different from the traditional data analysis technologies. The current storage
architecture is unable to meet the needs of big data applications. (2) Secondly, the mining of MBD has
become imminent. The original clinical data is large and heterogeneous, mostly from electronic medical
records, medical images, medical record parameters, laboratory results, and clinical observation and
interpretation [54]. This clinical information has its own particularity and complexity, such as diversity,
privacy, redundancy, incompleteness, and lack of mathematical properties. This makes great difference
between medical data mining and conventional data mining. (3) Thirdly, in the perspective of data
collection, large scale data is collected from various data sources like Internet, mobile phones, hospital,
and scientific community [55]. (4) Fourthly, there are many other challenges existed in both data
management and data analysis to support the big data era, for example, processing highly distributed
data sources, tracking data sources, coping with sampling bias and heterogeneity, and developing
parallel and distributed architecture algorithm.
Although we have obtained some interesting results through the bibliometric analysis and
visualization on MBD-related publications, this study has some shortcomings. We downloaded the
documents from SSCI and SCIE databases via Web of Science and more than 99% of the articles were
Sustainability 2018, 10, 166 16 of 18
written in English. This leads to underestimation of researchers who use other languages. In addition,
we have not considered the technologies for handling MBD.
Acknowledgments: The work was supported in part by the National Natural Science Foundation of China (Nos.
71501135, 71771156, and 71532007), the Scientific Research Foundation for Excellent Young Scholars at Sichuan University
(No. 2016SCU04A23), and the Scientific Research Foundation for Scholars at Sichuan University (No. YJ201535).
Author Contributions: The research is designed and performed by Huchang Liao and Ming Tang. The data was
collected by Ming Tang. Analysis of data was performed by Huchang Liao, Ming Tang, Li Luo, and Chunyang Li.
Finally, the paper is written by Huchang Liao, Ming Tang, Francisco Chiclana, and Xiao-Jun Zeng. All authors
read and approved the final manuscript.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Jin, X.L.; Wah, B.W.; Chen, X.Q.; Wang, Y.Z. Significance and challenges of big data research. Big Data Res.
2015, 2, 59–64. [CrossRef]
2. Binder, H.; Blettner, M. Big data in medical science-A biostatistical view. Dtsch. Arztebl. Int. 2015, 112,
137–142. [PubMed]
3. Katal, A.; Wazid, M.; Goudar, R.H. Big data: Issues, challenges, tools and good practices. In Proceedings
of the Sixth International Conference on Contemporary Computing (IC3), Noida, India, 8–10 August 2013;
pp. 404–409.
4. Wamba, S.F.; Akter, S.; Edwards, A.; Chopin, G.; Gnanzou, D. How ‘big data’ can make big impact: Findings
from a systematic review and a longitudinal case study. Int. J. Prod. Econ. 2015, 165, 234–246. [CrossRef]
5. Alles, M.G. Drivers of the use and facilitators and obstacles of the evolution of big data by the audit
profession. Account. Horiz. 2015, 29, 439–449. [CrossRef]
6. Huwe, T.K. Big data, big future. Comput. Lib. 2012, 32, 20–22.
7. Li, G.J.; Cheng, X.Q. Research status and scientific thinking of big data. Bull. Chin. Acad. Sci. 2012, 6, 647–657.
8. Jee, K.; Kim, G.H. Potentiality of big data in the medical sector: Focus on how to reshape the healthcare
system. Healthc. Inform. Res. 2013, 19, 79–85. [CrossRef] [PubMed]
9. Chawla, N.V.; Davis, D.A. Bringing big data to personalized healthcare: A patient-centered framework.
J. Gen. Intern. Med. 2013, 28, 660–665. [CrossRef] [PubMed]
10. Antman, E.M.; Benjamin, E.J.; Harrington, R.A.; Houser, S.R.; Peterson, E.D.; Bauman, M.A.; Brown, N.;
Bufalino, V.; Califf, R.M.; Creager, M.A.; et al. Acquisition, analysis, and sharing of data in 2015 and beyond:
A survey of the landscape. J. Am. Heart Assoc. 2015, 4, e002810. [CrossRef] [PubMed]
11. Merigó, J.M. Academic research in innovation: A country analysis. Scientometrics 2016, 108, 559–593.
[CrossRef]
12. Železnik, D.; Vošner, H.B.; Kokol, P. A bibliometric analysis of the Journal of Advanced Nursing, 1976–2015.
J. Adv. Nurs. 2017, 73, 2407–2419. [CrossRef] [PubMed]
13. Merigó, J.M.; Mas-Tur, A.; Roig-Tierno, N.; Ribeiro-Soriano, D. A bibliometric overview of the Journal of
Business Research between 1973 and 2014. J. Bus. Res. 2015, 68, 2645–2653. [CrossRef]
14. Osareh, F. Bibliometrics, citation analysis and co-citation analysis: A review of literature I. Libri 2009, 49,
149–158. [CrossRef]
15. Yeung, A.W.K.; Goto, T.K.; Leung, W.K. A bibliometric review of research trends in neuroimaging. Curr. Sci.
2017, 112, 725–734. [CrossRef]
16. Sweileh, W.M.; Al-Jabi, S.W.; Sawalha, A.F.; AbuTaha, A.S.; Saed, H.Z. Bibliometric analysis of publications
on Campylobacter: (2000–2015). J. Health Popul. Nutr. 2016, 35, 35–39. [CrossRef] [PubMed]
17. Merigó, J.M.; Blanco-Mesa, F.; Gil-Lafuente, A.M.; Yager, R.R. Thirty years of the International Journal of
Intelligent Systems: A bibliometric review. Int. J. Intell. Syst. 2017, 32, 526–554. [CrossRef]
18. Merigó, J.M.; Yang, J.B. A bibliometric analysis of operations research and management science. Omega 2016,
97, 1–16. [CrossRef]
19. Kostoff, R.N. The underpublishing of science and technology results. Scientist 2000, 14, 6.
20. Liu, W.S.; Liao, H.C. A bibliometric analysis of fuzzy decision research during 1970–2015. Int. J. Fuzzy Syst.
2017, 19, 1–14. [CrossRef]
Sustainability 2018, 10, 166 17 of 18
21. Yu, D.J.; Liao, H.C. Visualization and quantitative research on intuitionistic fuzzy studies. J. Intell. Fuzzy Syst. 2016,
30, 3653–3663. [CrossRef]
22. Powell, T.H.; Kouropalatis, Y.; Morgan, R.E.; Karhu, P. Mapping knowledge and innovation research themes:
Using bibliometrics for classification, evolution, proliferation and determinism. Int. J. Entrep. Innov. Manag.
2016, 20, 174–199. [CrossRef]
23. Garousi, V.; Mantyla, M.V. Citations, research topics and active countries in software engineering. Comput. Sci. Rev.
2016, 19, 56–77. [CrossRef]
24. Chen, C.M. CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific
literature. J. Assoc. Inf. Sci. Tech. 2006, 57, 359–377. [CrossRef]
25. Chen, C.M.; Hu, Z.; Liu, S.; Tseng, H. Emerging trends in regenerative medicine: A scientometric analysis in
CiteSpace. Expert Opin. Biol. Ther. 2012, 12, 593–608. [CrossRef] [PubMed]
26. Van Eck, N.J.; Waltman, L. Software survey: VOSviewer, a computer program for bibliometric mapping.
Scientometrics 2010, 84, 523–538. [CrossRef] [PubMed]
27. Cobo, M.J.; López-Herrera, A.G.; Herrera-Viedma, E.; Herrera, F. Science mapping software tools: Review,
analysis, and cooperative study among tools. J. Assoc. Inf. Sci. Tech. 2011, 62, 1382–1402. [CrossRef]
28. Bates, D.W.; Saria, S.; Ohnomachado, L.; Shah, A.; Escobar, G. Big data in health care: Using analytics
to identify and manage high-risk and high-cost patients. Health Affair. 2014, 33, 1123–1131. [CrossRef]
[PubMed]
29. Tahamtan, I.; Afshar, A.S.; Ahamdzadeh, K. Factors affecting number of citations: A comprehensive review
of the literature. Scientometrics 2016, 107, 1195–1225. [CrossRef]
30. Bertolibarsotti, L.; Lando, T. A theoretical model of the relationship between the h-index and other simple
citation indicators. Scientometrics 2017, 111, 1–34.
31. Bornmann, L.; Daniel, H.D. What do we know about the h index? J. Am. Soc. Inf. Sci. Technol. 2007, 58,
1381–1385. [CrossRef]
32. Díaz, I.; Cortey, M.; Olvera, À.; Segalés, J. Use of H-index and other bibliometric indicators to evaluate
research productivity outcome on swine diseases. PLoS ONE 2016, 11, e0149690. [CrossRef] [PubMed]
33. Li, H.J.; An, H.Z.; Wang, Y.; Huang, J.C.; Gao, X.Y. Evolutionary features of academic articles co-keyword
network and keywords co-occurrence network: Based on two-mode affiliation network. Phys. A 2016, 450,
657–669. [CrossRef]
34. Gu, D.X.; Li, J.J.; Li, X.G.; Liang, C.Y. Visualizing the knowledge structure and evolution of big data research
in healthcare informatics. Int. J. Med. Inform. 2017, 98, 22–32. [CrossRef] [PubMed]
35. Pinto, M.; Pulgarín, A.; Escalona, M.I. Viewing information literacy concepts: A comparison of two branches
of knowledge. Scientometrics 2014, 98, 2311–2329. [CrossRef]
36. Chung, K.F. Personalised medicine in asthma: Time for action. Eur. Respir. Rev. 2017, 26, 170064. [CrossRef]
[PubMed]
37. Schulkes, K.J.G.; Nguyen, C.; van den Bos, F.; Hamaker, M.E.; van Elden, L.J. Patient-centered outcome
measures in lung cancer trials. Lung 2016, 94, 647–652. [CrossRef] [PubMed]
38. Reyes, G.L.; Gonzalez, C.N.B.; Veloso, F. Using co-authorship and citation analysis to identify research
groups: A new way to assess performance. Scientometrics 2016, 108, 1171–1191. [CrossRef]
39. Von Haehling, S.; Anker, S.D. Cachexia as a major underestimated and unmet medical need: Facts and
numbers. J. Cachexia Sarcopenia Muscle 2010, 1, 1–5. [CrossRef] [PubMed]
40. Robinson, P.B.; Sexton, E.A. The effect of education and experience on self-employment success. J. Bus. Ventur.
1994, 9, 141–156. [CrossRef]
41. Regan, M.M.; Neven, P.; Giobbie-Hurder, A.; Goldhirsch, A.; Ejlertsen, B.; Mauriac, L.; Forbes Fracs, J.F.;
Lang, I.; Wardley, A.; Rabaglio, M.; et al. Assessment of letrozole and tamoxifen alone and in sequence for
postmenopausal women with steroid hormone receptor-positive breast cancer: The BIG 1-98 randomised
clinical trial at 8.1 years median follow-up. Lancet Oncol. 2011, 12, 1101–1108. [CrossRef]
42. Zhang, B.T.; Muhlenbein, H. Balancing accuracy and parsimony in genetic programming. Evol. Comput.
1995, 3, 17–38. [CrossRef]
43. Small, H. Co-citation in the scientific literature: A new measure of the relationship between two documents.
J. Am. Soc. Inform. Sci. 1973, 24, 265–269. [CrossRef]
Sustainability 2018, 10, 166 18 of 18
44. Boyack, K.W.; Klavans, R. Co-citation analysis, bibliographic coupling, and direct citation: Which citation
approach represents the research front most accurately? J. Assoc. Inf. Sci. Technol. 2010, 61, 2389–2404.
[CrossRef]
45. Murdoch, T.B.; Detsky, A.S. The inevitable application of big data to health care. JAMA J. Am. Med. Assoc.
2013, 309, 1351–1352. [CrossRef] [PubMed]
46. Hu, C.P.; Hu, J.M.; Gao, Y.; Zhang, Y.K. A journal co-citation analysis of library and information science in
China. Scientometrics 2011, 86, 657–670. [CrossRef]
47. Mirnezami, R.; Nicholson, J.; Darzi, A. Preparing for Precision Medicine. N. Engl. J. Med. 2012, 366, 489–491.
[CrossRef] [PubMed]
48. Hammer, M.J. Precision medicine and the changing landscape of research ethics. Oncol. Nurs. Forum 2016,
43, 149–150. [CrossRef] [PubMed]
49. Jameson, J.L.; Longo, D.L. Precision medicine—Personalized, problematic, and promising. N. Engl. J. Med.
2015, 372, 2229–2234. [CrossRef] [PubMed]
50. Wishart, D.S. Emerging applications of metabolomics in drug discovery and precision medicine. Nat. Rev.
Drug Discov. 2016, 17, 473–484. [CrossRef] [PubMed]
51. Aronson, S.J.; Rehm, H.L. Building the foundation for genomics in precision medicine. Nature 2015, 526,
336–342. [CrossRef] [PubMed]
52. Costa, F.F. Big data in biomedicine. Drug Discov. Today 2014, 19, 433–440. [CrossRef] [PubMed]
53. Kayaalp, M. Patient privacy in the era of big data. Balk. Med. J. 2017. [CrossRef] [PubMed]
54. Cios, K.J.; Moore, G.W. Uniqueness of medical data mining. Artif. Intell. Med. 2002, 26, 1–24. [CrossRef]
55. Huang, T.; Lan, L.; Fang, X.; An, P.; Min, J.; Wang, F. Promises and challenges of big data computing in health
sciences. Big Data Res. 2015, 2, 2–11. [CrossRef]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
